Back To Top
In The News

Massachusetts scientists scramble to meet anticipated demand for Covid drug

July 3, 2020

Drug companies racing to develop Covid treatments face an uphill battle to create the billions of doses that will likely be needed. It's a production push the likes of which the industry has never seen before.

NECI's Jenn Azar & Phil Braun discuss the need for automation. 

Read Full Article By Allison DeAngelis, Life Sciences Reporter of the Boston Business Journal

Related Stories